Company record
A clear public starting point.
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.
Startup in Sahin’s portfolio
CellType: company profile
Simulates drug response in human biology using LLMs.
Key Investors
- Sahin Boydas (Angel)
- Y Combinator
Why I Invested
As an angel investor in 234+ startups across 37 markets, I look for companies with exceptional founders, large addressable markets, and clear competitive advantages. CellType stood out in the Biotech space.